How should we evaluate the cost-effectiveness of CAR T-cell therapies? (2020)

First Author: Patel N

Attributed to: FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.hlpt.2020.03.002

Publication URI: http://dx.doi.org/10.1016/j.hlpt.2020.03.002

Type: Journal Article/Review

Parent Publication: Health Policy and Technology

Issue: 3